Current status and future perspective of natural killer cell therapy for cancer

Xiangyu Zhao1, Minghao Lin1, Xiaojun Huang1

  • 1Peking University People's Hospital, Peking University Institute of Hematology, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, National Clinical Research Center for Hematologic Disease, Beijing, China.

Medical Review (2021)
|January 18, 2024
PubMed

Insights

Natural killer (NK) cell therapy shows promise for cancer treatment. Enhancing NK cell proliferation and function is key to overcoming limitations and improving clinical application for better cancer elimination.

Area of Science:

  • Immunology
  • Oncology
  • Biotechnology

Background:

  • Natural killer (NK) cells have inherent cancer-fighting capabilities.
  • NK cell therapy faces challenges including poor proliferation and induced dysfunction in cancer patients.
  • Current clinical application of NK cell infusion is limited.

Purpose of the Study:

  • To provide a comprehensive analysis of NK cell therapy for cancer.
  • To discuss the current status and future prospects of NK cell therapy.
  • To focus on strategies for enhancing NK cell targeting and overcoming tumor immune suppression.

Main Methods:

  • Review of current literature on NK cell biology and therapy.
  • Analysis of biotechnological advancements in NK cell therapy.
  • Examination of strategies to improve NK cell function and overcome tumor microenvironment challenges.

Main Results:

  • NK cells are potent innate immune cells against cancer.
  • Challenges in NK cell proliferation and function hinder therapeutic efficacy.
  • Biotechnology offers potential solutions for enhancing NK cell therapy.

Conclusions:

  • NK cell therapy holds significant potential for cancer treatment.
  • Overcoming limitations in NK cell expansion and function is crucial for clinical success.
  • Targeting strategies and modulating the tumor microenvironment are key future directions.

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
921
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
1.7K
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
1.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
527
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
368